Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 5/20 | 0.56 |
| ▸ | NR1H3 | Q13133 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15353831 | 0.88 | NR1H2 (0.47) | NR1H2NR1H3ALDH1A1MAPK1MAPT | |
| SCHEMBL10050134 | 0.87 | NR1H2 (0.46) | NR1H2NR1H3ALDH1A1MAPK1MAPT | |
| SCHEMBL18327868 | 0.86 | NR1H2 (0.44) | NR1H2NR1H3ALDH1A1MAPK1MAPT | |
| SCHEMBL25849820 | 0.84 | NR1H2 (0.42) | NR1H2NR1H3ALDH1A1MAPK1MAPT | |
| SCHEMBL14560459 | 0.83 | NR1H2 (0.69) | NR1H2NR1H3ALDH1A1MAPK1MAPT | |
| SCHEMBL9836829 | 0.82 | NPC1 (0.49) | NR1H2NR1H3ALDH1A1MAPTMEN1 | |
| SCHEMBL8568473 | 0.81 | NR1H2 (0.61) | NR1H2NR1H3ALDH1A1MAPK1MAPT | |
| SCHEMBL16456162 | 0.81 | SENP1 (0.39) | NR1H2NR1H3ALDH1A1MAPTLMNA | |
| SCHEMBL9837963 | 0.81 | NR1H2 (0.50) | NR1H2NR1H3ALDH1A1MAPTKMT2A | |
| SCHEMBL7489174 | 0.80 | NR1H2 (0.40) | NR1H2NR1H3MAPTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9211510-B2 | Method for producing nanoparticles by forced ultrathin film rotary processing | M. TECHNIQUE CO., LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | M. TECHNIQUE CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20100155310-A1 | METHOD FOR PRODUCING NANOPARTICLES BY FORCED ULTRATHIN FILM ROTARY PROCESSING | M. TECHNIQUE CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| EP-2025733-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-02-18 | — | — | EP | disclosed |
| EP-0133156-B1 | 1,4-DIKETOPYRROLO-(3,4-C) PYRROLES | CIBA-GEIGY AG (CH) | 1991-07-10 | — | — | EP | disclosed |
| US-4666455-A | Compositions pigmented with N-substituted 1,4-diketopyrrolo-[3,4-c]-pyrroles | CIBA-GEIGY CORPORATION (US) | 1987-05-19 | — | — | US | disclosed |
| US-4585878-A | N-substituted 1,4-diketopyrrolo-[3,4-c]-pyrroles | CIBA-GEIGY CORPORATION (US) | 1986-04-29 | — | — | US | disclosed |
| EP-0133156-A2 | 1,4-Diketopyrrolo-(3,4-c) pyrroles | CIBA-GEIGY AG (CH) | 1985-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | ELP1, ELAVL1, ELF3 | NR1H2 1829/4885NR1H3 1235/4885ALDH1A1 1089/4885 |
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | OR10J3, PORCN, ABCG2 | NR1H2 1689/4885NR1H3 707/4885ALDH1A1 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.